We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Serum soluble toll-like receptor 4 and risk for clinical severity in COVID-19 patients

    Toll-like receptor 4 (TLR4) signaling mediates sustained systemic inflammation in(COVID)-19 patients. We aimed to assess the serum levels of sTLR4...

    Maha E. Houssen, Marwa O. Elmaria, ... Metwaly Ibrahim Mortada in Pneumonia
    Article Open access 05 January 2024
  2. Applications and clinical trial landscape using Toll-like receptor agonists to reduce the toll of cancer

    Toll-like receptors (TLRs), which serve as a bridge between innate and adaptive immunity, may be viable treatment targets. TLRs are the first line of...

    Christian Rolfo, Elisa Giovannetti, ... Aung Naing in npj Precision Oncology
    Article Open access 08 March 2023
  3. Toll-like receptor 5 and Toll-like receptor 9 single nucleotide polymorphisms and risk of systemic lupus erythematosus and nephritis in Egyptian patients

    Background

    Toll-like (TLRs) play a crucial role in both adaptive and innate immunity. The aim of the present study was to assess the association of...

    Ola Mohammad Gharbia, Sherine Abdel Rahman Bassiouni, ... Mostafa Abdelsalam in Egyptian Rheumatology and Rehabilitation
    Article Open access 11 December 2021
  4. Toll-like receptors 1, 2, 4, 5, and 6 in gastric cancer

    Toll-like receptors (TLRs) are expressed on both immune cells and tumor cells, triggering both anti-tumor and pro-tumor responses. Therefore, TLRs...

    Maarit Eskuri, Niko Kemi, ... Joonas H Kauppila in Virchows Archiv
    Article 26 September 2023
  5. Randomized controlled trial of vitamin d supplementation on toll-like receptor-2 (tlr-2) and toll-like receptor-4 (tlr-4) in tuberculosis spondylitis patients

    Background

    Tuberculosis spondylitis accounts for approximately 50% of all cases of skeletal tuberculosis. Vitamin D plays a role in the immune system....

    Jainal Arifin, Muhammad Nasrum Massi, ... Muhammad Phetrus Johan in Journal of Orthopaedic Surgery and Research
    Article Open access 21 December 2023
  6. Correlation between Toll-like Receptor Gene Polymorphisms and Idiopathic Nephrotic Syndrome in Chinese Children

    Objective

    Idiopathic nephrotic syndrome (INS) is the most common glomerular disease in children. Toll-like receptors (TLRs) have been reported to be...

    Hui-hui Gao, Wei Li, ... Jian-hua Mao in Current Medical Science
    Article 28 April 2023
  7. Mutated Toll-like receptor 9 increases Alzheimer’s disease risk by compromising innate immunity protection

    The development of Alzheimer’s disease (AD) involves central and peripheral immune deregulation. Gene identification and studies of AD genetic...

    Rita Cacace, Lujia Zhou, ... Christine Van Broeckhoven in Molecular Psychiatry
    Article Open access 11 July 2023
  8. Castration immunoregulates toll-like receptor-4 in male bladder cancer

    Purpose

    Among diverse Pattern Recognition Receptors (PRRs), Toll-like receptor-4 (TLR-4) is a key urothelial trigger for innate immune response...

    Leonardo Oliveira Reis, Ana Clara Ciglioni Salustiano, ... Fernandes Denardi in International Urology and Nephrology
    Article 08 August 2022
  9. Toll-like receptor-3 contributes to the development of aortic valve stenosis

    Aortic valve stenosis (AS) development is driven by distinct molecular and cellular mechanisms which include inflammatory pathways....

    Sven Thomas Niepmann, Nicola Willemsen, ... Sebastian Zimmer in Basic Research in Cardiology
    Article Open access 01 February 2023
  10. Evaluation of adropin, fibroblast growth factor-1 (FGF-1), and Toll-like receptor-1 (TLR1) biomarkers in patients with inflammatory bowel disease: gene expression of TNF-α as a marker of disease severity

    Background

    Inflammatory bowel disease (IBD) is a chronic relapsing inflammatory disorder of unknown etiology and unpredictable course. The aim of the...

    Moushira Zaki, Hisham A. Orban, ... Hala T. El-Bassyouni in Egyptian Journal of Medical Human Genetics
    Article Open access 05 June 2024
  11. Elevated expression of Toll-like receptor 7 and its correlation with clinical features in patients with primary Sjögren’s syndrome

    Background

    The labial salivary glands (LSGs) are important for the diagnosis, evaluation of therapeutic efficacy, and genetic analyses of primary...

    Huimin Yang, Chao Sun, ... Zhijun Li in Advances in Rheumatology
    Article Open access 04 March 2024
  12. The Toll-like Receptor-2/4 Antagonist, Sparstolonin B, and Inflammatory Diseases: A Literature Mining and Network Analysis

    Background

    Sparstolonin B (SsnB) is characterized as a new toll-like receptor (TLR)-2/4 antagonist. However, the effects of SsnB on different...

    Rongyuan Yang, Qingqing Liu, ... Qing Liu in Cardiovascular Drugs and Therapy
    Article 25 January 2024
  13. Achaete-scute complex-like 2 regulated inflammatory mechanism through Toll-like receptor 4 activating in stomach adenocarcinoma

    Background

    To investigate the role of achaete-scute complex-like 2 (ASCL2) in stomach adenocarcinoma (STAD), we analyze whether ASCL2 suppression...

    Enqi Zheng, Zhun Cai, ... Qian Fang in World Journal of Surgical Oncology
    Article Open access 25 August 2022
  14. The relationship between Toll-like receptor-4 genes and preeclampsia outcomes

    Purpose

    The study aimed to analyse the relationship of the rs4986790 locus of the TLR4 gene with the overall risk of preeclampsia, including both its...

    Almagul Kurmanova, Gulfairuz Urazbayeva, ... Makhambet Smailov in Journal of Assisted Reproduction and Genetics
    Article 31 May 2024
  15. Immortalised canine buccal epithelial cells’ CXCL8 secretion is affected by allergen extracts, Toll-like receptor ligands, IL-17A and calcitriol

    Epithelial cells are known to produce mediators which can influence the behaviour of neighbouring immune cells. Although the oral mucosa has gained...

    Michael Pelst, Clara Höbart, ... Eric Cox in Veterinary Research
    Article Open access 13 September 2022
  16. Genetic variation in toll-like receptor 4 gene with primary antiphospholipid syndrome susceptibility: a cohort of Egyptian patients

    Background

    As toll-like receptor 4 ( TLR4 ) plays important roles in cellular immunity and TLR4 polymorphisms have been shown to be associated with...

    Sara H. Mahdy, Nour M. Abd Elkader, ... Mostafa M. ElHady in Egyptian Journal of Medical Human Genetics
    Article Open access 02 November 2022
  17. Enteric Toll-like receptor 7 stimulation causes acute exacerbation in lupus-susceptible mice

    Autoimmune diseases are often accompanied by acute exacerbation. However, the mechanism underlying systemic lupus erythematosus (SLE) flares remains...

    Yudai Takase, Mirei Shirakashi, ... Motomu Hashimoto in Clinical Rheumatology
    Article 14 December 2022
  18. Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma

    Glioma represents a fast proliferating and highly invasive brain tumor which is resistant to current therapies and invariably recurs. Despite some...

    Yang Xun, Hua Yang, ... Hua You in Journal of Hematology & Oncology
    Article Open access 29 October 2021
  19. Variants in transient receptor potential channels and toll-like receptors modify airway responses to allergen and air pollution: a randomized controlled response human exposure study

    Background

    Environmental co-exposure to allergen and traffic-related air pollution is common globally and contributes to the exacerbation of...

    Andrew Robinson, Ryan D. Huff, ... Chris Carlsten in Respiratory Research
    Article Open access 07 September 2023
  20. Phospholipase D4 as a signature of toll-like receptor 7 or 9 signaling is expressed on blastic T-bet + B cells in systemic lupus erythematosus

    Background

    In systemic lupus erythematosus (SLE), autoreactive B cells are thought to develop by-passing immune checkpoints and contribute to its...

    Ken Yasaka, Tomohide Yamazaki, ... Hiroshi Fujii in Arthritis Research & Therapy
    Article Open access 16 October 2023
Did you find what you were looking for? Share feedback.